Literature DB >> 36127622

Long Non-coding RNA LINC01224 Promotes the Malignant Behaviors of Triple Negative Breast Cancer Cells via Regulating the miR-193a-5p/NUP210 Axis.

Kai Sang1, Tongbo Yi1, Chi Pan1, Jian Zhou1, Lei Yu2.   

Abstract

Triple negative breast cancer (TNBC) is a prevalent malignant tumor in women and is characterized by high incidence and mortality. Current evidence has suggested that multiple long noncoding RNAs (lncRNAs) play regulatory roles in TNBC, while the specific mechanism of LINC01224 in TNBC remains unclear. In this study, LINC01224 was highly expressed in TNBC cells. Moreover, LINC01224 downregulation inhibited TNBC cell proliferation, migration, and invasion, and promoted cell apoptosis. Additionally, LINC01224 stabilized NUP210 mRNA through interaction with miR-193a-5p, thereby aggravating the malignant phenotypes of TNBC. Overall, LINC01224 functions as a tumor promoter for TNBC.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  LINC01224; NUP210; TNBC; miR-193a-5p

Year:  2022        PMID: 36127622     DOI: 10.1007/s12033-022-00555-4

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.860


  45 in total

Review 1.  Unique features of long non-coding RNA biogenesis and function.

Authors:  Jeffrey J Quinn; Howard Y Chang
Journal:  Nat Rev Genet       Date:  2016-01       Impact factor: 53.242

Review 2.  Breast cancer in young women: an overview.

Authors:  Zoi Anastasiadi; Georgios D Lianos; Eleftheria Ignatiadou; Haralampos V Harissis; Michail Mitsis
Journal:  Updates Surg       Date:  2017-03-04

Review 3.  Triple-Negative Breast Cancer: Next-Generation Sequencing for Target Identification.

Authors:  Jonathan D Marotti; Francine B de Abreu; Wendy A Wells; Gregory J Tsongalis
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

Review 4.  Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy.

Authors:  Jonathan Chou; David A Quigley; Troy M Robinson; Felix Y Feng; Alan Ashworth
Journal:  Cancer Discov       Date:  2020-02-18       Impact factor: 39.397

Review 5.  Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer.

Authors:  Qiaorui Tan; Sha Yin; Dongdong Zhou; Yajing Chi; Xiaochu Man; Huihui Li
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

Review 6.  Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies.

Authors:  Antonio Marra; Dario Trapani; Giulia Viale; Carmen Criscitiello; Giuseppe Curigliano
Journal:  NPJ Breast Cancer       Date:  2020-10-16

Review 7.  Updates in the Evaluation and Management of Breast Cancer.

Authors:  Ciara C O'Sullivan; Charles L Loprinzi; Tufia C Haddad
Journal:  Mayo Clin Proc       Date:  2018-06       Impact factor: 7.616

Review 8.  The Landscape of Targeted Therapies in TNBC.

Authors:  Elena Vagia; Devalingam Mahalingam; Massimo Cristofanilli
Journal:  Cancers (Basel)       Date:  2020-04-08       Impact factor: 6.639

9.  Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma.

Authors:  Mengjia Song; Ailin Zhong; Jieying Yang; Junyi He; Shaoyan Cheng; Jianxiong Zeng; Yue Huang; Qiuzhong Pan; Jingjing Zhao; Ziqi Zhou; Qian Zhu; Yan Tang; Hao Chen; Chaopin Yang; Yuan Liu; Xiaocong Mo; Desheng Weng; Jian-Chuan Xia
Journal:  Aging (Albany NY)       Date:  2019-11-23       Impact factor: 5.682

10.  Long Noncoding RNA DCST1-AS1 Promotes Cell Proliferation and Metastasis in Triple-negative Breast Cancer by Forming a Positive Regulatory Loop with miR-873-5p and MYC.

Authors:  Li Tang; Yuli Chen; Xun Tang; Da Wei; Xinyu Xu; Feng Yan
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.